Research Articles
Preventing Nozzle Clogging in High-Cell-Density Bioinks: A Comprehensive Guide for Robust Bioprinting
This article provides a systematic guide for researchers and drug development professionals tackling nozzle clogging, a major bottleneck in the bioprinting of high-cell-density constructs essential for creating physiologically relevant tissue...
In Situ Bioprinting in Surgery: Current Breakthroughs, Clinical Applications, and Future Pathways
In situ bioprinting represents a paradigm shift in regenerative medicine, enabling the direct deposition of cells and biomaterials into defect sites during surgical procedures.
Omnidirectional 3D Bioprinting: Advanced Strategies for Complex Tissue Engineering and Drug Development
This article explores the transformative potential of omnidirectional 3D bioprinting, a suite of advanced fabrication techniques that overcome the limitations of traditional layer-by-layer manufacturing.
Intramyocardial Injection for Local Paracrine Delivery: A Strategic Approach for Cardiac Regeneration
This article comprehensively reviews intramyocardial injection as a targeted strategy for local paracrine delivery in cardiac repair.
Evaluating Cellular Identity Preservation: From Foundational Concepts to Advanced Methods in Biomedicine
This article provides a comprehensive evaluation of methods for preserving and verifying cellular identity, a critical challenge in cell-based therapies and single-cell genomics.
PureCap Method: Revolutionizing mRNA Purification for Safer and More Effective Therapeutics
This article details the PureCap method, a groundbreaking technological advancement that enables the purification of completely capped mRNA with near-100% efficiency.
Strategies for Addressing Batch Variation in Autologous Cell Therapy Manufacturing
This article provides a comprehensive guide for researchers and drug development professionals on managing batch variation in autologous cell products.
Engineering Hypoimmune Cells for Allogeneic Therapy: Strategies, Applications, and Clinical Frontiers
Allogeneic cell therapies derived from healthy donors or induced pluripotent stem cells (iPSCs) offer transformative potential for treating cancer, diabetes, and autoimmune diseases by providing 'off-the-shelf' availability.
Contamination Control in Cell Therapy Manufacturing: A 2025 Strategic Guide for Risk Reduction and Quality Assurance
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on establishing a robust contamination control strategy (CCS) for cell therapy manufacturing.
Overcoming Immune Rejection in Allogeneic Cell Therapy: Strategies for 'Off-the-Shelf' Therapeutics
Allogeneic cell therapies offer a scalable, 'off-the-shelf' alternative to autologous treatments but face significant barriers from host immune rejection and graft-versus-host disease (GvHD).